Cambridge Research Anavar 50 is presented in a 60 tablet bottle. Each tablet reportedly contains 50 milligrams of oxandrolone according to the label and packaging. Samples of this product were purchased from a European-based authorized reseller and internet source between the dates of June 1, 2015 and June 30, 2015. The samples were forwarded and received by the analytical laboratory SIMEC AG for HPLC-UV testing July 10, 2015. The quantitative dosage testing report was completed on July 23, 2015. The product was identified with the batch number J196TA.
The Oxandrolone hormone does not carry any estrogenic related side effects. It does not aromatize and cannot lead to gynecomastia or water retention due to increases in estrogen levels. It further carries no progestin related activity, which again supports no estrogenic related side effects. Due to water retention being impossible with this steroid, this will decrease the risk of high blood pressure. Excess water retention can promote high blood pressure. Some steroids that do not aromatize can lead to high blood pressure, such as Trenbolone , but Anavar is rarely associated with this trait.